Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.

被引：0
|
作者：
Shikdar, Sufana
Day, Silas
Ikeguchi, Alexandra
Ying, Yuan
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Med Ctr, Oklahoma City, OK USA
[3] Stephenson Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21505
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Toxicity, response, and survival in older adults with metastatic melanoma treated with checkpoint inhibitors.
    De Glas, Nienke A.
    Bastiaannet, Esther
    Van den Bos, Frederiek
    Mooijaart, Simon
    Van der Veldt, Astrid Aplonia Maria
    Suijkerbuijk, Karijn
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Boers-Sonderen, Marye
    Van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    Hospers, Geke
    Haanen, John B. A. G.
    Piersma, Djura
    Van Rijn, Rozemarijn
    Ten Tije, A. J.
    Wouters, Michel W. J. M.
    Portielje, Johanna Elisabeth A.
    Kapiteijn, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
    Saint-Ghislain, Mathilde
    Derrien, Anne-Celine
    Geoffrois, Lionnel
    Gastaud, Lauris
    Lesimple, Thierry
    Negrier, Sylvie
    Penel, Nicolas
    Kurtz, Jean-Emmanuel
    Le Corre, Yannick
    Dutriaux, Caroline
    Gardrat, Sophie
    Barnhill, Raymond
    Matet, Alexandre
    Cassoux, Nathalie
    Houy, Alexandre
    Ramtohul, Toulsie
    Servois, Vincent
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Stern, Marc-Henri
    Rodrigues, Manuel
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : 105 - 112
  • [23] Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
    Kelly, Deirdre
    Rose, April A. N.
    Muniz, Thiago Pimentel
    Hogg, David
    Butler, Marcus O.
    Saibil, Samuel D.
    King, Ian
    Kamil, Zaid Saeed
    Ghazarian, Danny
    Ross, Kendra
    Iafolla, Marco
    Araujo, Daniel, V
    Waldron, John
    Laperriere, Normand
    Krema, Hatem
    Spreafico, Anna
    CANCERS, 2021, 13 (14)
  • [24] Similar overall survival in tebentafusp-treated 2L+metastatic uveal melanoma regardless of prior immunotherapy
    Piulats, J. M.
    Sato, T.
    Luke, J. J.
    Collins, L.
    Edukulla, R.
    Abdullah, S. E.
    Leyvraz, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S854 - S854
  • [25] A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma
    Piulats Rodriguez, J. M.
    Piperno-Neumann, S.
    Rutkowski, P.
    Nathan, P.
    Hassel, J. C.
    Espinosa, E.
    De la Cruz Merino, L.
    Ochsenreither, S.
    Shoushtari, A. N.
    Orloff, M.
    Salama, A. K. S.
    Watkins, C.
    Goodall, H.
    Baurain, J-F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S924 - S924
  • [26] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
  • [27] Immune checkpoint inhibitors in a cohort of 206 metastatic uveal melanomas patients
    Saint-Ghislain, M.
    Geoffrois, L.
    Gastaud, L.
    Lesimple, T.
    Negrier, S.
    Penel, N.
    Kurtz, J-E.
    Le Corre, Y.
    Gardrat, S.
    Barnhill, R.
    Cassoux, N.
    Mariani, P.
    Servois, V.
    Piperno-Neumann, S.
    Rodrigues, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [28] OVERALL SURVIVAL ON TEBENTAFUSP IN METASTATIC UVEAL MELANOMA (MUM) ACROSS THE RANGE OF TUMOR GP100 EXPRESSION LEVELS
    Leach, Emma
    Stanhope, Sarah
    Naidoo, Revashnee
    Abdullah, Shaad
    Collins, Laura
    Ranade, Koustubh
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A909 - A909
  • [29] Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
    Sander, Michael
    Stukalin, Igor
    Vallerand, Isabelle A.
    Goutam, Siddhartha
    Ewanchuk, Benjamin W.
    Meyers, Daniel E.
    Pabani, Aliyah
    Morris, Don
    Heng, Daniel Y. C.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB170 - AB170
  • [30] Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
    Sander, Michael S.
    Stukalin, Igor
    Vallerand, Isabelle A.
    Goutam, Siddhartha
    Ewanchuk, Benjamin W.
    Meyers, Daniel E.
    Pabani, Aliyah
    Morris, Don G.
    Heng, Daniel Y. C.
    Cheng, Tina
    CANCER MEDICINE, 2021, 10 (08): : 2618 - 2626
12345